Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$133.48

1.26 (0.95%)

16:25
08/14/18
08/14
16:25
08/14/18
16:25

GW Pharmaceuticals initiated with a Buy at Stifel

Stifel analyst Paul Matteis started GW Pharmaceuticals with a Buy rating and $181 price target. The analyst expects a "strong" Epidiolex launch in Dravet/Lennox Gastaut with use in refractory pediatric epilepsy and put an 80% odds-of-success for Epidiolex in Tuberous Sclerosis complex. The latter could de-risk another $250M in on-label sales, Matteis tells investors in a research note. The analyst's epilepsy physician survey suggests broad physician and patient awareness of Epidiolex ahead of the launch and he believes the 2019 consensus sales estimate of $115M "seems doable." His believes Epidiolex will hit $1.5B in U.S. sales in 2023.

GWPH GW Pharmaceuticals
$133.48

1.26 (0.95%)

06/26/18
BOFA
06/26/18
NO CHANGE
Target $200
BOFA
Buy
GW Pharmaceuticals price target raised to $200 from $170 at BofA/Merrill
06/26/18
GSCO
06/26/18
NO CHANGE
Target $188
GSCO
Buy
Goldman Sachs positive on GW Pharmaceuticals' Epidiolex label
Goldman Sachs analyst Salveen Richter notes that GW Pharmaceuticals received FDA approval for Epidiolex in patients two-years of age and older for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. The analyst points out that approval was largely expected post the unanimous vote for approval at the FDA Adcom as well as the compelling profile from three Phase 3 clinical trials and one open-label extension study. Richter is positive on the label given its breadth and the lack of adjunctive therapy requirement, thus enabling the drug to be prescribed as monotherapy. The analyst recommends owning GW Pharma into the launch, and reiterates a Buy rating and $188 price target on the shares.
04/20/18
MZHO
04/20/18
NO CHANGE
Target $51
MZHO
Buy
Mizuho reiterates Buy on Zogenix after GW Pharmaceuticals FDA panel
After an FDA panel unanimously voted in favor of approving GW Pharmaceuticals' (GWPH) Epidiolex, Mizuho analyst Difei Yang reiterates a Buy rating on Zogenix (ZGNX) with a $51 price target. Superior efficacy of Zogenix competitor ZX008, as demonstrated in the most recent Phase 3 results, means that FDA approval would be highly likely assuming positive data from the second Phase 3 study, expected in June, Yang tells investors in a research note. She believes readouts on the study could be an important share moving event and are "highly likely" to be positive.
04/19/18
CANT
04/19/18
NO CHANGE
Target $205
CANT
Overweight
GW Pharmaceuticals price target raised to $205 from $192 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for GW Pharmaceuticals to $205 and reiterates an Overweight rating on the shares after an FDA advisory committee voted 13-0 that the benefit-risk profile of cannabidiol is favorable for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome in patients two years of age and older.

TODAY'S FREE FLY STORIES

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

17:46
09/20/18
09/20
17:46
09/20/18
17:46
Recommendations
Pier 1 Imports analyst commentary  »

Pier 1 Imports price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$46.06

1.01 (2.24%)

17:43
09/20/18
09/20
17:43
09/20/18
17:43
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron reverses, now down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

ACXM

Acxiom

$50.28

2.09 (4.34%)

, IPG

Interpublic Group

$22.68

0.315 (1.41%)

17:41
09/20/18
09/20
17:41
09/20/18
17:41
Hot Stocks
Acxiom shareholders approve AMS sale, will switch name to LiveRamp after close »

Acxiom (ACXM) announced…

ACXM

Acxiom

$50.28

2.09 (4.34%)

IPG

Interpublic Group

$22.68

0.315 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

IPCI

Intellipharmaceutics

$2.92

0.15 (5.42%)

17:39
09/20/18
09/20
17:39
09/20/18
17:39
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$301.53

-10.71 (-3.43%)

17:30
09/20/18
09/20
17:30
09/20/18
17:30
Hot Stocks
Northrop Grumman completes first qualification test of rocket motor in Atlas V »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

$88.96

0.39 (0.44%)

17:28
09/20/18
09/20
17:28
09/20/18
17:28
Recommendations
Yum! Brands analyst commentary  »

Yum! Brands continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

17:25
09/20/18
09/20
17:25
09/20/18
17:25
Conference/Events
SEC to hold an investor roundtable »

Investor Roundtable to…

FSCT

ForeScout

$39.56

1.2 (3.13%)

17:24
09/20/18
09/20
17:24
09/20/18
17:24
Hot Stocks
ForeScout beneficial owner Amadeus Capital Partners sells $4.6M in shares »

ForeScout beneficial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MU

Micron

$46.06

1.01 (2.24%)

17:23
09/20/18
09/20
17:23
09/20/18
17:23
Hot Stocks
Micron says it is seeing CPU shortage »

Says confident of long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

CWK

Cushman & Wakefield

$18.00

0.37 (2.10%)

17:21
09/20/18
09/20
17:21
09/20/18
17:21
Hot Stocks
Cushman & Wakefield arranges $55M sale of a Whole Foods property »

A 50,451-square-foot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$19.08

3.97 (26.27%)

17:17
09/20/18
09/20
17:17
09/20/18
17:17
Hot Stocks
Acadia issues states affirming positive risk profile of NUPLAZID »

ACADIA Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

17:16
09/20/18
09/20
17:16
09/20/18
17:16
Hot Stocks
United Natural Foods plunges after Q4 margins fall to 14.5% »

Shares of United Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

MDXG

MiMedx

$6.18

0.68 (12.36%)

17:15
09/20/18
09/20
17:15
09/20/18
17:15
Hot Stocks
MiMedx announces Nasdaq listing extension »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

MDXG

MiMedx

$6.18

0.68 (12.36%)

17:15
09/20/18
09/20
17:15
09/20/18
17:15
Hot Stocks
MiMedx: Previous executive separations to be treated as termination 'for cause' »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

UTX

United Technologies

$141.91

1.41 (1.00%)

17:11
09/20/18
09/20
17:11
09/20/18
17:11
Hot Stocks
United Technologies awarded $2.46B Department of Defense contract modification »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEXA

Nexa Resources

$11.89

0.1 (0.85%)

17:10
09/20/18
09/20
17:10
09/20/18
17:10
Hot Stocks
Nexa Resources authorizes $30M share buyback program »

Nexa Resources has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AT

Atlantic Power

$2.15

-0.025 (-1.15%)

17:06
09/20/18
09/20
17:06
09/20/18
17:06
Hot Stocks
Atlantic Power to acquire two biomass plants in South Carolina for $13M »

Atlantic Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.00

0.4 (2.04%)

17:05
09/20/18
09/20
17:05
09/20/18
17:05
Hot Stocks
Vanda Pharmaceuticals announces HETLIOZ patent listing in FDA Orange Book »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

WRD

WildHorse Resource

$21.31

-0.12 (-0.56%)

17:05
09/20/18
09/20
17:05
09/20/18
17:05
Hot Stocks
WildHorse Resource adds acreage in Burleson, Brazos, Lee, Washington Counties »

WildHorse Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell (RDS.A)…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

APC

Anadarko

$63.86

-0.88 (-1.36%)

EQNR

Equinor

$26.45

-0.09 (-0.34%)

CVX

Chevron

$119.46

-0.04 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

MU

Micron

$46.06

1.01 (2.24%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Earnings
Micron sees Q1 EPS $2.95, +/- 7c, consensus $2.73 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

AL

Air Lease

$45.80

0.09 (0.20%)

, EADSY

Airbus

$0.00

(0.00%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Hot Stocks
Air Lease announces delivery of Airbus A320-200neo aircraft with SKY »

Air Lease (AL) announced…

AL

Air Lease

$45.80

0.09 (0.20%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MU

Micron

$46.06

1.01 (2.24%)

16:52
09/20/18
09/20
16:52
09/20/18
16:52
Hot Stocks
Micron says it achieved record revenue in FY18 »

Says expects 1ynm sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

PMBC

Pacific Mercantile Bancorp

$9.75

0.025 (0.26%)

16:50
09/20/18
09/20
16:50
09/20/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

EJF Capital reports 7.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MU

Micron

$46.06

1.01 (2.24%)

16:46
09/20/18
09/20
16:46
09/20/18
16:46
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron up 5.7% to $48.69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.